Janus Henderson Horizon Biotechnology Fund H2 HEUR

WKN A3DGG0 | ISIN LU2441283277 |  Fonds
Factsheet

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU1176839154 Protea Fund - Sectoral Biotech Opportunities Fund IF USD +16,50 % +22,08 % 0,66
2 LU0942225912 Candriam Equities L Biotechnology, R - Capitalisation +16,34 % +22,19 % 0,65
3 LU2208649280 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD +16,36 % +22,46 % 0,64
4 LU0400035332 UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse Q-acc, USD +16,12 % +22,46 % 0,63
5 LU0133360163 Candriam Equities L Biotechnology, I - Capitalisation +15,58 % +22,00 % 0,62
54 LU2441283277 Janus Henderson Horizon Biotechnology Fund H2 HEUR +8,75 % +28,48 % 0,24
85 LU0415392678 Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating -8,13 % +14,17 % -0,72
86 LU0415392249 Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating -8,77 % +14,17 % -0,76
87 LU2719280096 Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 CHF - Accumulating -9,12 % +14,54 % -0,76
88 LU0415392835 Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating -9,23 % +14,54 % -0,77
89 LU0415392595 Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating -9,86 % +14,54 % -0,82